COMMUNIQUÉS West-GlobeNewswire

OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test
20/06/2019
MIAMI, June 20, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that the Company has submitted a de novo request to the U.S. Food and Drug Administration (FDA) seeking regulatory clearance for the [...]
Albireo Announces Launch of “PFIC Voices”
20/06/2019
New Initiative to Create Awareness and Understanding of Life-Threatening Pediatric Liver Disease Announced new PFIC Voices website, www.PFICvoices.com BOSTON, June 20, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. ( [...]
VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
20/06/2019
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Alimera’s ILUVIEN® Receives Positive NICE Recommendation for Non-Infectious Posterior Uveitis
20/06/2019
NICE decision is key milestone expanding access to patients in the United Kingdom ATLANTA, June 20, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and [...]
BioSig Technologies Issues June 2019 Shareholder Letter
20/06/2019
Top Tier New Corporate Talent and First Successful Clinical Results from Leading Medical Institutions Pave Way for Commercial Rollout Santa Monica, CA, June 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ [...]
BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML)
20/06/2019
Company to Host Investor Conference Call and Webcast of Mid-2019 Clinical Data Updates Today, Thursday, June 20 at 8:00 a.m. EDT CAMBRIDGE, Mass. and BEIJING, China, June 20, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. ( [...]
Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729
20/06/2019
- AB-729 is a subcutaneously-administered RNAi agent targeting HBV replication and HBsAg antigen production - Supports corporate objective to combine AB-729 with AB-506, Arbutus’ proprietary oral capsid inhibitor [...]
T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019
20/06/2019
Real-world data to highlight substantial impact T2Bacteria® has made on patient outcomes LEXINGTON, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of [...]
Radient Technologies Inc. Provides Update on Progress of Cannabis and Hemp Extraction Facilities and Issues Shares for Services
20/06/2019
EDMONTON, Alberta, June 20, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce it has awarded the mandate for the second phase of [...]
Theratechnologies Launches Direct-to-Consumer Campaigns for TROGARZO® and EGRIFTA® in the United States
20/06/2019
MONTREAL, June 20, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the launch of two direct-to-consumer campaigns for TROGARZO ® (ibalizumab-uiyk) for injection and [...]
Theratechnologies lance deux campagnes publicitaires aux États-Unis axées vers les usagers potentiels de TROGARZO(MD) et d’EGRIFTA(MD)
20/06/2019
MONTRÉAL, 20 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer le lancement de deux campagnes publicitaires axées vers les usagers potentiels de TROGARZO MD ( [...]
Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership
20/06/2019
Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs BASEL, Switzerland and CORBEIL- [...]
Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019
20/06/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019 Oxford, UK, and Cambridge, MA, US, 20 June 2019 – Summit Therapeutics [...]
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union
20/06/2019
San Diego, CA, June 20, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes [...]
Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives
20/06/2019
Investment to fund strategic growth initiatives across the diverse and expanding synthetic biology end market REDWOOD CITY, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading synthetic [...]
Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility
20/06/2019
TORONTO, June 20, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/06/2019
MISSION VIEJO, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
Parallax Health Sciences Announces Initiative to Obtain a 510(K) Clearance for its Fotodigm® Enabled Remote Patient Monitoring Platform
20/06/2019
Positions Fotodigm ® to be Issued a CPT Code for Medical Billing SANTA MONICA, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an [...]
TeraRecon Receives First-of-Kind FDA Determination
20/06/2019
DURHAM, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- Advanced visualization and artificial intelligence (AI) technology provider, TeraRecon, today announced it has successfully completed an FDA regulatory review of its [...]

Pages